- Home
- TSHA vs NBB Comparison
TSHA vs NBB Comparison
Compare TSHA & NBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- NBB
- Stock Information
- Founded
- TSHA 2019
- NBB 2009
- Country
- TSHA United States
- NBB United States
- Employees
- TSHA N/A
- NBB N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- NBB Finance Companies
- Sector
- TSHA Health Care
- NBB Finance
- Exchange
- TSHA Nasdaq
- NBB Nasdaq
- Market Cap
- TSHA 397.8M
- NBB 462.1M
- IPO Year
- TSHA 2020
- NBB N/A
- Fundamental
- Price
- TSHA $2.13
- NBB $15.54
- Analyst Decision
- TSHA Strong Buy
- NBB
- Analyst Count
- TSHA 8
- NBB 0
- Target Price
- TSHA $6.63
- NBB N/A
- AVG Volume (30 Days)
- TSHA 3.0M
- NBB 73.9K
- Earning Date
- TSHA 05-16-2025
- NBB 01-01-0001
- Dividend Yield
- TSHA N/A
- NBB 8.64%
- EPS Growth
- TSHA N/A
- NBB N/A
- EPS
- TSHA N/A
- NBB N/A
- Revenue
- TSHA $8,333,000.00
- NBB N/A
- Revenue This Year
- TSHA N/A
- NBB N/A
- Revenue Next Year
- TSHA N/A
- NBB N/A
- P/E Ratio
- TSHA N/A
- NBB N/A
- Revenue Growth
- TSHA N/A
- NBB N/A
- 52 Week Low
- TSHA $1.05
- NBB $13.67
- 52 Week High
- TSHA $4.32
- NBB $16.66
- Technical
- Relative Strength Index (RSI)
- TSHA 58.69
- NBB 51.60
- Support Level
- TSHA $1.85
- NBB $15.01
- Resistance Level
- TSHA $2.28
- NBB $15.74
- Average True Range (ATR)
- TSHA 0.26
- NBB 0.19
- MACD
- TSHA 0.03
- NBB 0.04
- Stochastic Oscillator
- TSHA 52.96
- NBB 68.35
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.